Correlating quantitative real-time PCR to rapid diagnostic test and RNA transcript expression in isolated gametocytemia and asexual parasitemia of Plasmodium falciparum malaria by Rachel Lau et al.
Lau et al. Tropical Diseases, Travel Medicine and Vaccines  (2015) 1:8 
DOI 10.1186/s40794-015-0008-3RESEARCH Open AccessCorrelating quantitative real-time PCR to
rapid diagnostic test and RNA transcript
expression in isolated gametocytemia and
asexual parasitemia of Plasmodium
falciparum malaria
Rachel Lau1, Melissa Phuong2, Filip Ralevski1 and Andrea K. Boggild1,3,4*Abstract
Background: At present, only microscopic examination of stained thick and thin blood smears for malaria can
differentiate clinically relevant asexual parasitemia from clinically irrelevant isolated gametocytemia. Microscopy is
time consuming, labour intensive, and requires significant technical expertise to perform. Simple and rapid tests
that can distinguish asexual from isolated sexual parasitemia are needed.
Methods: To determine if parasitemia and cycle threshold (CT) values on Plasmodium genus and P. falciparum-specific
quantitative polymerase chain reaction (qPCR) assays correlate to positivity of rapid diagnostic test (RDT), and 18S rRNA
gene copy number, we analyzed blood samples from Ontario patients with isolated P. falciparum gametocytemia or
asexual stages. RNA transcripts were evaluated to determine whether there is correlation of expression to different life
cycle stages of P. falciparum.
Results: 45 specimens containing isolated P. falciparum gametocytes, and 40 specimens containing isolated asexual
stages by microscopy were identified and analyzed. By RDT, 40 of 45 (88.9 %) isolated gametocytemia specimens and
40 of 40 (100 %) asexual-stage specimens were positive for Plasmodium falciparum-specific histidine rich protein-2
(HRP-2). Fourteen of 45 (31.1 %) isolated gametocytemia specimens, and 36 of 40 (90 %) asexual-stage specimens were
positive for Plasmodium genus aldolase T2 band. Positivity of the aldolase T2 band was associated with lower mean
Plasmodium genus and P. falciparum-specific CT values, and to higher mean 18S rRNA gene copy by qPCR for both
isolated gametocytemia and asexual-stage specimens. There was also a negative correlation of asexual parasitemia to
both CT values, and positive correlation to 18S rRNA gene copy number. Analysis of asexual stage-specific erythrocyte
binding antigen (eba-175) transcripts on 25 isolated gametocytemia and 20 asexual-stage specimens gave a positive
predictive value of 62.5 % and negative predictive value of 100 % for asexual parasitemia. Thus, an absence of eba-175
transcripts excluded the presence of asexual (clinically relevant) parasitemia.
Conclusions: Positivity of the aldolase T2 band of BinaxNow RDT correlated to higher parasite load in both isolated
gametocytemia and asexual-stage specimens. Asexual stage-specific eba-175 RNA transcript expression provided
reasonable negative predictive value for exclusion of asexual parasitemia in clinical samples, but was present in both
isolated gametocytemia and asexual stage specimens.* Correspondence: andrea.boggild@utoronto.ca
1Public Health Ontario Laboratories, Public Health Ontario, Toronto, Canada
3Tropical Disease Unit, Division of Infectious Diseases, UHN-Toronto General
Hospital, 200 Elizabeth Street, 13EN-218, Toronto, ON M5G 2C4, Canada
Full list of author information is available at the end of the article
© 2015 Lau et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this
article, unless otherwise stated.
Lau et al. Tropical Diseases, Travel Medicine and Vaccines  (2015) 1:8 Page 2 of 9Background
Prompt and accurate diagnosis of malaria is essential to
limiting morbidity and mortality due to this imported
parasitic infection [1]. Several tests are employed in the
clinical parasitology laboratory to diagnose malaria, and
these commonly include thick and thin Giemsa-stained
blood smears for direct examination of parasitized eryth-
rocytes; rapid antigen detection via immunochromato-
graphic test; and amplification of parasite genomic
material via PCR using qualitative or quantitative assays.
Each of these laboratory tests has its own advantages
and limitations, and unique performance characteristics
[2, 3]. However, only direct examination of blood smears
can, to date, reliably differentiate asexual parasitemia,
which is clinically relevant, from sexual parasitemia or
gametocytemia, which is clinically irrelevant meaning
that these stages do not require treatment for resolution
of malaria. Isolated gametocytemia is relevant from a
public health perspective, as gametocytes are infectious to
biting Anopheles mosquitoes present in parts of North
America. Although rapid diagnostic (antigen) tests (RDTs)
are a useful adjunct to direct examination of blood
smears, they are unable to distinguish current from
past infection due to antigen persistence following in-
fection [4, 5], and the presence of gametocytes [6].
Similarly, commonly employed PCR assays amplify
conserved targets, such as 18S, present in both asex-
ual and sexual stage parasites [7, 8].
Understanding a patient’s parasitemia status over time
will guide the course of treatment. If a patient remains
symptomatic while on malaria treatment due to the
presence of asexual stages (and potentially increasing
asexual parasitemia), then this may reflect drug resist-
ance or clinical failure. Conversely, if that patient re-
mains symptomatic with fever but only sexual
parasitemia is noted, then an alternate explanation for
ongoing or recurrent symptoms would be pursued, ra-
ther than invoking drug-related issues. As RDT will re-
main positive for weeks after treatment [4, 5], and
expertise in microscopy at hospital-based hematology la-
boratories is becoming increasingly scarce, PCR is play-
ing an increasingly important and relevant role in the
clinical management of malaria patients. Thus, identify-
ing non-microscopy based tests with equal ability to
identify stage and quantitation of parasites as micros-
copy is essential as our understanding of a patient’s on-
going parasitemia stage has direct clinical relevance.
The extent to which quantitative real time PCR results
correlate to level of positivity on rapid diagnostic tests
(RDTs) or CT values when isolated gametocytemia is
present in clinical samples is unknown, but could be
useful for delineating laboratory “markers” or flags of
isolated sexual parasitemia (gametocytemia) when smear
results are unavailable or non-diagnostic for eitherquantitation or species identification. We sought to de-
termine if parasitemia and CT values on Plasmodium
genus and P. falciparum-specific PCR assays and 18S
rRNA gene copy number by quantitative real time PCR
correlate to positivity of RDT in clinical samples from
Ontario containing isolated P. falciparum gametocyte-
mia or asexual stages by expert microscopy. As well, we
evaluated RNA transcript markers that may differentiate
sexual from asexual stages of P. falciparum.
Methods
Clinical samples
Samples included in this analysis were 45 biobanked mal-
aria specimens with isolated P. falciparum gametocytemia
noted at microscopy, and a random sampling of 10 each of
specimens with the following ranges of P. falciparum asex-
ual parasitemia (rings, trophozoites, and/or schizont
stages) quantitated by expert microscopy: <0.1; 0.1–1.0;
1.0–10.0; and >10.0 %. Anonymized parasitologic data on
positive malaria specimens examined at the Public Health
Ontario Laboratories (PHOL) were also extracted from the
secure biobank database, and analyzed.
Rapid diagnostic test
Rapid diagnostic test (RDT) results for each specimen
were acquired at the time of specimen processing in the
clinical parasitology laboratory using the BinaxNOW
Malaria RDT kit (Inverness Professional Medical Diag-
nostics, Scarborough, ME). Results were expressed as
“positive” or “negative” at each of the Plasmodium fal-
ciparum-specific histidine rich protein-2 (HRP-2) and
Plasmodium genus aldolase T2 bands, and were not
quantified subjectively or objectively.
Isolation of parasite and human DNA
200 μL of frozen whole blood from each specimen were
thawed from −80 °C freezer. DNA were extracted with
QIAamp DNA Mini kit (QIAGEN Sciences, German-
town, MD) using the DNA extraction protocol for blood.
60 μL of DNA were eluted for each specimen.
Plasmodium qualitative and quantitative real time PCR
Plasmodium Genus and P.falciparum/P.vivax duplex
species-specific real time PCR (qPCR) assays on 18S
rRNA were performed in triplicate, and P.malariae/
P.ovale duplex species-specific qPCR to exclude mixed
infections were performed, as described [7, 8]. Human
macro-globin qPCR were run as a positive extraction
control [9]. To quantitate the 18S rRNA gene copy num-
ber for each clinical sample in the reaction, control P.
falciparum DNA was serially diluted ranging from 11.7
million to 0.117 gene copies/reaction and was included
in each run. Log gene copy numbers vs CT values were
plotted, and the standard curve and equation generated
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each clinical sample. Parasitemia of <0.1 % was assigned
a value of 0.01 in order to determine the correlation be-
tween parasitemia with CT values and copy number.
Average gene copy number for each sample was calcu-
lated from Plasmodium genus and P. falciparum
species-specific qPCR runs.Isolation of parasite and human RNA and cDNA synthesis
RNA was extracted from 200 μL of frozen whole blood
using Macherey-Nagel Nucleospin RNA Blood Kit
(Bethlehem, PA) with DNase digestion and eluted with
60 μL nuclease-free water. 15 μL of RNA was used for
cDNA synthesis with Quanta qScript cDNA Synthesis
Kit (Cat# 95047–100, Quanta Biosciences, Gaithersburg,
MD).Asexual stages transcript expression
To determine if there was differential transcript ex-
pression between sexual and asexual stages samples,
RNA transcripts of three genes were analyzed:
erythrocyte binding antigen 175 (eba-175), chloro-
quine resistance transporter (pfcrt) and merozoite ap-
ical erythrocyte binding ligand (maebl), which were
previously shown to be expressed exclusively in the asexual
stages of P. falciparum [10–12]. Forward and reverse
primers spanning exon/intron junctions to avoid any false
positives on residual DNA in the RNA extracts were de-
signed for asexual stage-specific expression erythrocyte
binding antigen 175 gene (eba-175, Gene ID: 2654998)
fwd 5′ GGAGGCTTTTTCAAGTATGGCCA 3′, rev 5′
CATAACTCCTTCAGAACTTTGA 3′; Plasmodium fal-
ciparum chloroquine resistance transporter (pfcrt, Gene
ID: 2655199) fwd 5′ AAACACAGTCGTAGAGAAT
TGTGGTC 3′, rev 5′ AATGCGAAGGTTTTCCATGCT
3′; maebl (Gene ID: 811029) fwd 5′ TTTAAAAAAA
AGGAATTTTCAAACATG 3′, rev 5′ GTAGC
TTCTTCAAACCACTTTC 3′ and housekeeping myosin
gene as extraction control (Gene ID: 813699) fwd 5′ TAT
CAGAGACAAAAATAAAGTTTG 3′ and rev’ 5′
CGAATCAAATAAGTCTAAATTTCG 3′. RNA tran-
scripts were amplified with Amplitaq Gold Fast Master
Mix (Life Technologies), 500nM of each primer and 2 μL
of cDNA in a total volume of 20 μL. PCR conditions were
95 °C for 10 min followed by 40 cycles of 96 °C for 5 s,
60 °C (pfcrt)/58 °C (eba-175)/56 °C (maebl and myosin)
for 5 s, 68 °C for 5 s with a final extension of 72 °C for
30 s. 10 μL of amplified product was visualized on 2.5 %
Agarose gel at 100 V for 1 h and stained with ethidium
bromide. The intensity of the eba-175 positive bands was
quantitated by Quantity One software (BioRad, Hercules,
CA) and percentage over background was calculated.Statistical analysis
Descriptive statistics were performed for all continuous
and categorical parasitologic variables. Differences be-
tween categorical variables were compared using Fisher’s
Exact Test. Differences between continuous variables
were compared using Student’s t-test, or in the case of
non-normally distributed variables, Mann Whitney Rank
Sum test. Correlation was performed with Pearson r.
Performance characteristics of eba-175 PCR were calcu-
lated using microscopy as the gold standard. Sensitivity,
specificity, positive predictive value (PPV), and negative
predictive value (NPV) are reported for eba-175 tran-
script expression in asexual parasitemia. All statistical
computations were performed using Graphpad Prism 5
(Graphpad Software, Inc. La Jolla, CA). Level of signifi-
cance was set at p < 0.05.
Results
Clinical samples
We identified 85 P. falciparum positive specimens from
our de-identified malaria biobank, with storage at −80 C
between August 2008 and April 2014. Forty-five speci-
mens contained only sexual stages (gametocytes) by ex-
pert microscopy, and 40 contained only asexual stages
(rings, trophozoites, schizonts) by expert microscopy. Of
45 isolated gametocytemia specimens, 34 had previously
submitted specimens that were positive for isolated asex-
ual stages, thus, the gametocytemia specimens were post-
treatment in these 34 cases. For 11 specimens, no prior
sample had been submitted. Parasitologic metrics are
described in Table 1. All 45 isolated gametocytemia speci-
mens had parasitemia of <0.1 %, whereas the 40 asexual-
stage samples had parasitemias ranging from <0.1 to 34 %.
All specimens were confirmed to contain isolate P. falcip-
arum infection by species-specific qPCR.
Rapid diagnostic test
Forty of 45 (88.9 %) isolated gametocytemia specimens,
were positive for Plasmodium falciparum-specific histi-
dine rich protein-2 (HRP-2; T1 band) by Binax NOW
RDT (Table 1). Fourteen of 45 isolated gametocytemia
specimens (31.1 %) were positive for pan-Plasmodium
aldolase (aldolase T2 band) by Binax NOW RDT
(Table 1). All 40 isolated asexual-stages specimens were
positive for the HRP-2 (T1) band, and 36 out of 40
(90 %) were positive for the aldolase T2 band (Table 2).
Quantitative real time PCR of specimens with isolated
gametocytemia
Mean Plasmodium genus CT value for 44 specimens was
31.64 ± 0.50 (median 31.6, range 26.2–39.8). One speci-
men was undetectable by Plasmodium genus qPCR but
was detectable by P. falciparum species-specific qPCR
(Sample #1, Table 1). Specimens with positive aldolase
Table 1 Parasitologic factors, quantitative PCR results, and RNA transcript expression in 45 Plasmodium falciparum positive
specimens with isolated gametocytemia by expert microscopy




StDev Ave 18S rRNA
gene copy#/rxn
eba-175 myosin
1 Gametocytes <0.1 + - 39.8 0.1 - - 4 + +
2 Gametocytes <0.1 + - - - 39.8 0.8 6 + -
3 Gametocytes <0.1 + - 38.5 0.6 37.7 0.8 30 + +
4 Gametocytes <0.1 - - 38.3 0.1 36.9 0.5 43 ND ND
5 Gametocytes <0.1 - - 37.5 0.1 37.5 0.9 69 ND ND
6 Gametocytes <0.1 + - 35.5 0.4 34.8 1.0 287 ND ND
7 Gametocytes <0.1 + - 35.1 0.2 34.6 1.1 331 ND ND
8 Gametocytes <0.1 + - 35.5 0.6 33.6 1.4 506 ND ND
9 Gametocytes <0.1 + - 33.4 0.1 33.8 1.7 672 ND ND
10 Gametocytes <0.1 + - 34.2 0.2 33.3 1.4 687 ND ND
11 Gametocytes <0.1 + - 33.2 0.1 33.4 1.0 803 ND ND
12 Gametocytes <0.1 + - 34.1 0.4 32.4 1.1 814 ND ND
13 Gametocytes <0.1 + - 33.0 0.1 32.7 0.9 1046 ND ND
14 Gametocytes <0.1 + + 33.2 0.3 32.4 0.8 1195 + +
15 Gametocytes <0.1 + - 33.6 0.6 31.3 0.3 1214 - +
16 Gametocytes <0.1 + - 32.5 0.4 31.7 0.5 1251 + +
17 Gametocytes <0.1 + - 32.5 0.6 32.2 0.8 1422 + +
18 Gametocytes <0.1 + - 33.5 0.4 31.1 0.8 1525 ND ND
19 Gametocytes <0.1 + - 31.8 0.4 32.1 1.0 1754 ND ND
20 Gametocytes <0.1 + - 31.6 0.3 32.1 1.2 1801 ND ND
21 Gametocytes <0.1 + - 32.3 0.6 31.7 1.1 1854 ND ND
22 Gametocytes <0.1 + - 31.5 0.3 31.3 0.0 1905 + +
23 Gametocytes <0.1 - - 31.5 0.3 30.5 0.4 2530 - +
24 Gametocytes <0.1 + - 32.2 0.8 30.9 0.8 2573 - +
25 Gametocytes <0.1 + - 32.0 0.5 30.4 0.9 3267 - +
26 Gametocytes <0.1 - - 30.7 0.3 31.0 1.2 3300 - +
27 Gametocytes <0.1 + - 31.3 0.1 30.5 0.9 3422 ND ND
28 Gametocytes <0.1 + - 30.2 0.3 29.9 0.2 4374 + +
29 Gametocytes <0.1 + - 29.9 0.4 30.0 0.9 5640 ND ND
30 Gametocytes <0.1 + - 30.2 0.1 29.7 0.7 5928 - +
31 Gametocytes <0.1 + + 30.7 0.8 28.8 0.5 5967 + +
32 Gametocytes <0.1 + + 30.0 0.1 29.3 0.8 7246 ND ND
33 Gametocytes <0.1 + + 29.8 0.2 29.2 0.8 7694 - +
34 Gametocytes <0.1 + + 29.6 0.2 28.9 0.9 8996 - +
35 Gametocytes <0.1 + - 29.3 0.1 28.9 1.1 9686 + +
36 Gametocytes <0.1 + + 28.6 0.4 29.1 1.0 10539 ND ND
37 Gametocytes <0.1 - + 28.8 0.2 28.5 0.5 11110 ND ND
38 Gametocytes <0.1 + + 28.4 0.7 27.5 0.5 14285 + +
39 Gametocytes <0.1 + + 28.2 0.4 27.5 0.2 18236 + +
40 Gametocytes <0.1 + + 27.6 0.3 27.9 1.1 20566 - +
41 Gametocytes <0.1 + + 26.9 0.3 26.7 0.2 34485 - +
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Table 1 Parasitologic factors, quantitative PCR results, and RNA transcript expression in 45 Plasmodium falciparum positive
specimens with isolated gametocytemia by expert microscopy (Continued)
42 Gametocytes <0.1 + - 26.7 0.2 26.4 0.6 42605 ND ND
43 Gametocytes <0.1 + + 26.3 0.7 26.2 0.3 50031 - +
44 Gametocytes <0.1 + + 26.5 0.1 26.0 0.8 51397 - +
45 Gametocytes <0.1 + + 26.2 0.3 25.5 0.1 65208 - +
ND not determined
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± 0.52 (median 28.5, range 26.2–33.2) by Plasmodium
genus qPCR. Specimens with negative aldolase T2 bands
by RDT (N = 30) had a mean CT value of 33.05 ± 0.53 (me-
dian 32.5, range 26.7–39.8) (p < 0.001 compared to those
with positive aldolase T2 bands) by Plasmodium genus
qPCR. Mean P. falciparum-specific CT value for 44 speci-
mens was 31.04 ± 0.49 (median 31.0, range 25.5–39.8).
One specimen was undetectable by P. falciparum species-
specific qPCR but was detectable by Plasmodium genus
qPCR (Sample #2, Table 1). Specimens with positive aldol-
ase T2 bands by RDT (N = 14) had a mean CT value of
28.11 ± 0.47 (median 28.2, range 25.5–32.4) by P. falcip-
arum-specific qPCR. Specimens with negative aldolase T2
bands by rapid antigen test (N = 30) had a mean CT value
of 32.41 ± 0.52 (median 31.9, range 26.4–39.8) by P. falcip-
arum-specific qPCR (p < 0.001). Mean P. falciparum 18S
rRNA gene copy number per reaction for the 45 specimens
with isolated gametocytemia was 9073.4 ± 2288.6 (median
2530.0, range 4–65208). Specimens with positive aldolase
T2 bands by RDT (N = 14) had a mean P. falciparum 18S
rRNA gene copy number of 21925.4 ± 5386.0 (median
12697.5, range 1195–65208). Specimens with negative al-
dolase T2 bands by RDT (N = 31) had a mean P. falcip-
arum 18S rRNA gene copy number of 3269.3 ± 1365.7
(median 1422.0, range 4–42605) (p < 0.001).
Quantitative real time PCR of specimens with isolated
asexual stages
Parasitemia of asexual-stage specimens ranged from
<0.1 to 34 % with Plasmodium genus CT values from
14.1 to 28.8; P. falciparum-specific CT values from
14.5 to 28.8, and 18S rRNA gene copy number from
7287 to 50,542,052 (Table 2). Log parasitemia was in-
versely correlated with both Plasmodium genus and
P. falciparum-specific CT values (Pearson r, p < 0.001).
Furthermore, parasitemia was positively correlated
with copy number (Pearson r, p < 0.001). Four of 40
(10 %) specimens were negative for the aldose band
on RDT, and all had low parasitemia of <0.1 %. Spec-
imens with positive aldolase T2 band by RDT had
mean Plasmodium genus CT value of 19.31 ± 0.52
(median 19.2, range 14.1–25.6) and mean P. falcip-
arum-specific CT value of 19.46 ± 0.51 (median 19.1,
range 14.5–26.2). Specimens with negative aldolase T2band by RDT had mean Plasmodium genus CT value of
26.23 ± 1.04 (median 26, range 24.1–28.8) and mean P.
falciparum-specific CT value of 26.58 ± 0.99 (median 26.6,
range 24.3–28.8) (p < 0.001 vs those with a positive aldol-
ase T2 band). Mean 18S rRNA gene copy number for
specimens with positive aldolase T2 bands by RDT was
8,637,126 ± 2,285,803 (median 2,751,036, range 41,458–
50,542,052) and for specimens with negative aldolase T2
bands by RDT was 50,109.5 ± 24,808.1 (median 37,914,
range 7287–117,324) (p < 0.001). Higher asexual parasit-
emia was also associated with positivity of the aldolase T2
band, with 6 out of 10 (60 %) of <0.1 % parasitemia being
aldolase T2 band-positive, compared to 30 out of 30
(100 %) specimens with ≥0.1 % parasitemia being aldolase
T2 band-positive (Fisher’s Exact Test, p = 0.002).Expression of asexual stage-specific transcripts
An initial analysis of 3 asexual and 3 gametocytemia speci-
mens at all three genes showed no amplification of eba-175
on all 3 gametocytemia samples whereas pfcrt and maebl
showed 3 and 2 amplifications respectively (data not
shown) and thus eba-175 was chosen for further analysis.
Due to the limited number of primary specimens available,
a subset of 25 isolated gametocytemia and 20 asexual-
stages specimens were analyzed. All 20 (100 %) asexual
stages specimens, and 12 out of 25 (48 %) isolated gameto-
cytemia specimens demonstrated eba-175 expression
(Tables 1 and 2; Fig. 1). To ensure there was no cross-
reactivity of human cDNA and P. falciparum DNA, 2 hu-
man cDNA and 8 P. falciparum DNA extracts were tested
with both eba-175 and myosin PCR and no cross-reactivity
was observed. Using microscopy as the gold standard, eba-
175 PCR demonstrated 100 % sensitivity and 52 % specifi-
city for asexual parasitemia, with a PPV of 62.5 % and NPV
of 100 % (Table 3). The mean band intensity in isolated
gametocytemia specimens was 107 % ± 2.6 % (median
104 %, range 101–133 %) and in asexual-stage specimens
was 147 % ± 9.3 % (median 134 %, range 101–216 %). Thus,
there was higher eba-175 transcript expression in asexual-
stage specimens than in isolated gametocytemia specimens
(Mann Whitney, p < 0.001). The mean age of individuals
with eba-175 positive specimens was 37 years (range 16–61
years) versus 44 years (range 2–64 years) for eba-175 nega-
tive specimens, and these were not significantly different.
Table 2 Parasitologic factors, quantitative PCR results, and RNA transcript expression in 40 Plasmodium falciparum positive
specimens with isolated asexual-stages by expert microscopy




StDev Ave 18S rRNA
gene copy#/rxn
eba-175 myosin
46 Rings <0.1 + - 28.8 0.9 28.8 0.4 7287 ND ND
47 Rings, Trophs <0.1 + - 26.9 0.8 27.5 0.3 18727 ND ND
48 Rings <0.1 + + 25.6 0.7 26.2 0.5 41458 + +
49 Rings <0.1 + - 25.1 0.6 25.7 0.2 57100 ND ND
50 Rings <0.1 + + 24.2 0.9 24.6 0.6 103941 ND ND
51 Rings <0.1 + + 24.0 0.9 24.5 1.2 116491 + +
52 Rings <0.1 + - 24.1 1.0 24.3 0.5 117324 + +
53 Rings <0.1 + + 24.0 0.8 24.2 0.3 126258 + -
54 Rings <0.1 + + 21.1 0.6 21.5 0.4 700623 + +
55 Rings <0.1 + + 20.5 0.9 20.8 0.5 1058503 + +
56 Rings 0.1 + + 21.5 1.0 20.7 0.6 876634 + +
57 Rings 0.2 + + 23.6 1.3 23.2 0.6 209649 + +
58 Rings 0.2 + + 22.6 1.0 22.3 0.4 362408 ND ND
59 Rings, Trophs 0.2 + + 22.0 0.5 22.2 0.2 440742 ND ND
60 Rings 0.2 + + 21.6 1.1 20.9 0.5 798231 + +
61 Rings, Trophs 0.3 + + 20.9 0.7 21.2 0.2 818001 + +
62 Rings, Trophs 0.3 + + 20.6 0.8 20.1 0.5 1351301 + -
63 Rings 0.4 + + 21.2 0.8 21.8 0.6 606025 + -
64 Rings, Trophs 0.4 + + 21.5 1.2 21.3 0.6 684146 + +
65 Rings 0.4 + + 20.9 0.6 21.1 0.5 821066 + -
66 Rings, Trophs 1.1 + + 18.7 0.9 18.5 0.5 3761262 + +
67 Rings 1.2 + + 20.7 0.8 20.7 0.6 1067665 + -
68 Rings, Trophs 1.8 + + 19.2 1.0 19.0 0.6 2758211 ND ND
69 Rings, Trophs,
Schizonts
2.6 + + 17.5 0.7 17.6 0.4 6849735 ND ND
70 Rings, Trophs 3.0 + + 19.2 0.8 19.1 0.3 2743861 ND ND
71 Rings 3.0 + + 17.6 0.4 18.4 0.2 5318426 + +
72 Rings, Trophs 3.8 + + 17.2 0.8 17.5 0.7 7901115 + +
73 Rings, Trophs 3.8 + + 17.2 1.0 17.2 0.4 9026304 ND ND
74 Rings, Trophs 4.0 + + 17.2 0.8 17.3 0.8 8628101 ND ND
75 Rings 4.3 + + 17.1 0.7 17.8 0.3 7438110 ND ND
76 Rings 10.4 + + 17.4 1.0 17.3 0.5 8171936 + +
77 Rings 11.6 + + 17.4 0.7 17.5 0.2 7541456 ND ND
78 Rings 12.6 + + 16.6 0.9 16.6 0.1 13147859 + +
79 Rings 13.0 + + 14.2 0.7 14.6 0.6 46984798 ND ND
80 Rings, Trophs 14.0 + + 14.1 0.9 14.5 0.7 50542052 ND ND
81 Rings, Trophs 16.0 + + 16.7 0.6 17.3 0.6 9825903 ND ND
82 Rings 18.0 + + 16.9 1.2 17.2 0.5 9827129 ND ND
83 Rings 21.1 + + 15.6 0.9 16.1 0.2 19863776 ND ND
84 Rings 24.0 + + 14.5 0.7 14.9 0.3 39213307 ND ND
85 Rings, Trophs 34.0 + + 14.4 0.5 14.9 0.5 41210046 ND ND
ND not fetermined
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Fig. 1 Eba-175 and myosin transcript expression. M, DNA Ladder; LM, Low Range DNA Ladder; 1 and 2, isolated P. falciparum gametocytemia
cDNA (sample # 30 and 35); 3 and 4, asexual P. falciparum parasitemia cDNA (sample # 60 and 66); 5, human cDNA; 6, P. falciparum DNA; 7, blank
negative control
Lau et al. Tropical Diseases, Travel Medicine and Vaccines  (2015) 1:8 Page 7 of 9Discussion
Malaria is a potentially life-threatening imported infec-
tion, with 1,687 cases diagnosed in the United States in
2012, the majority of which occurred in those traveling
to visit friends and relatives [13]. Malaria is an illness of
particular public health importance as it is vector-borne,
and has the potential to emerge in North America with
expansion of the range of Anopheles vectors [14], and in-
creasing importation from the tropics, particularly by
certain high-risk types of travelers who may be semi-
immune with asymptomatic parasitemia [15, 16]. Given
that malaria is life-threatening, potentially emergent, and
of public health importance, it is of great relevance to
the health of North Americans. Asexual stages (i.e.,
rings, trophozoites and schizonts) are clinically relevant
stages, whereas sexual stages (i.e., gametocytes) are clin-
ically irrelevant to the human host, meaning that they
do not require treatment for resolution of malaria. Ga-
metocytes, however can be taken up by Anopheles mos-
quitoes via a blood meal, thus perpetuating the
Plasmodium life cycle. In this regard, gametocytemia is
relevant from a public health and disease transmission
perspective, but has little relevance to the clinician car-
ing for an ill patient, or the laboratorian communicating





Isolated asexual stages (N)
eba-175 Positive 20
eba-175 Negative 0
Performance Characteristics Sensitivityc = 100 %
apositive predictive value for asexual parasitemia, calculated as (true positives)/(true
bnegative predictive value for asexual parasitemia, calculated as (true negatives)/(tr
csensitivity for asexual parasitemia, calculated as (true positives)/(true positives + fal
dspecificity for asexual parasitemia, calculated as (true negatives)/(true negatives + fMicroscopy remains the gold-standard diagnostic test for
malaria, but with ongoing attrition of microscopy expertise
in clinical laboratories across North America, hospitals and
labs are increasingly reliant on non-parasitologic testing
methods such as RDT and molecular assays. However,
these tests cannot reliably differentiate asexual from sexual
parasitemia, and are thereby limited in their clinical per-
formance characteristics, both for new diagnoses of mal-
aria, and for following response to treatment. Both RDT
and PCR can remain positive long after successful treat-
ment of malaria, and resolution of clinical symptoms [17].
At present, use of PCR is fairly restricted to reference la-
boratories, though PCR plays an increasingly important
role in quality control of both microscopy and RDT, and in
investigating febrile returned travelers at high risk of mal-
aria, but with negative smear and RDT results [18]. Thus,
defining and optimizing the best possible diagnostic strat-
egies for malaria, and the life stages of Plasmodium should
be a priority.
We have demonstrated that the BinaxNOW commer-
cial RDT and a validated qPCR based on the Plasmo-
dium 18S rRNA region were unable to differentiate
asexual from sexual stages of P. falciparum, however, the
presence of the pan-Plasmodium aldolase T2 band was
correlated to both higher parasitemia by microscopy andpression compared to gold-standard microscopy for identification
Predictive
valuesIsolated sexual stages (Gametocytes) (N)
12 PPVa = 62.5 %
13 NPVb = 100 %
Specificityd = 52 %
positives + false positives)
ue negatives + false negatives)
se negatives)
alse positives)
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sistent with previous research in which the absence of
the aldolase T2 band served as a reasonable basis on
which to rule out high parasitemia [19]. Although RNA
transcript expression of eba-175 had a low positive pre-
dictive value (62.5 %) in this study, it provided a negative
predictive value of 100 % for asexual stages, suggesting
that it is potentially a good marker to rule-out asexual
parasitemia in specimens received at the laboratory.
Band intensity of eba-175 transcript expression was also
greater in specimens containing asexual stages by mi-
croscopy. The low specificity (52 %) and positive predict-
ive value observed in this study may be explained by
sub-microscopic level of asexual stages, or any residual
eba-175 transcripts leftover from prior asexual stages in
the isolated gametocytemia specimens. It is known that
both symptomatic and asymptomatic individuals may
carry sub-microscopic infections with P. falciparum.
Moreover, sub-microscopic infections have been re-
ported to be persistent and produce gametocytes. As mi-
croscopy and RDT are limited in their ability to detect
these infections, especially in endemic populations, PCR
assays have the potential to further detect sub-
microscopic parasitemia [18, 20]. Furthermore, it may be
possible that residual transcripts from asexual stages re-
main in the circulation during a patient’s recovery. In an
analysis comparing microscopy, RDT and qPCR results,
we found that the 18S rRNA DNA can circulate in the
bloodstream even after parasites are no longer observed
in Giemsa-stained blood smears (Boggild unpubl. data).
Given this observation, slow clearance of the eba-175
transcript may also be a possibility.
Microscopy is the gold standard for diagnosis of mal-
aria, and identification of the different life stages is crit-
ical to provision of appropriate treatment. For instance,
a patient who continues to have fever while on malaria
treatment or thereafter will be managed differently if
asexual parasitemia continues compared to isolated
sexual-stage parasitemia. Expert microscopy demands a
high level of training and skill, and in malaria non-
endemic countries, this expertise is a challenge to
maintain; hence, an increasing reliance on RDT and
molecular assays, which may not provide adequate dif-
ferentiation of asexual from sexual stages during the in-
vestigation of a febrile returned traveler, or during
follow-up parasitemia while the patient is on anti-
malarial treatment. As microscopy expertise is lost over
time in malaria non-endemic areas, PCR and RDT are
being increasingly used for malaria confirmation. In
those circumstances, eba-175’s high NPV sufficiently ex-
cludes asexual parasitemia in a specimen that may be
positive for HRP-2 antigenemia by RDT and possibly for
18S rRNA,or some other molecular target, by PCR.
Thus, the ultimate goal should not be to confirm thepresence of gametocytes, but rather, the absence of asex-
ual stages such as rings and trophozoites. Further re-
search into markers of isolated asexual or sexual
parasitemia, whether RNA transcripts or expressed pro-
teins, that provide both high positive and negative pre-
dictive values is warranted.
Several limitations of this analysis should be acknowl-
edged. Our small sample size reflected the availability of
specimens, and the limited volume of primary samples
available for RNA transcript analysis. However, we in-
cluded all specimens in our biobank with isolated game-
tocytes during the inclusion period of August 2008 to
April 2014 in this study. In future, a larger sample size
with time-series analysis and clinical linkage will more
rigorously identify the role of eba-175 transcript expres-
sion in the diagnosis and follow-up of malaria. Such an
analysis will become more important as microscopy ex-
pertise in clinical laboratories continues to wane. Sec-
ond, the low specificity and PPV of eba-175 for asexual
specific-stages limits our ability to use this target as a
rule-in test. On the other hand, we demonstrated 100 %
NPV for exclusion of asexual stages, which reinforces
the utility of eba-175 as a “rule-out” test for clinically
relevant stages of P. falciparum.
Conclusions
Asexual stage-specific eba-175 RNA transcript expres-
sion provided reasonable negative predictive value for
exclusion of asexual parasitemia in clinical samples, but
was present in both isolated gametocytemia and asexual
stage specimens.
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